Video: Interview With Christopher Viehbacher Of Gurnet Point Capital
Executive Summary
Since his departure from Sanofi, Viehbacher has taken on a significant role in venture capital; at the recent BioPharm America conference, he spoke about his company's business model and goals, as well as the trend of pharma execs moving to smaller companies.
BOSTON – Formerly the CEO of Sanofi, Christopher Viehbacher has moved into the venture capital realm, now serving as managing partner of Boston-based Gurnet Point Capital. Prior to addressing the BioPharm America 2015 conference on Sept. 15, Viehbacher spoke with "The Pink Sheet" about the recent trend of big pharma executives moving into roles with smaller companies, putting them closer to innovation, and about the deal-making atmosphere for biopharmaceuticals.
BioPharm America 2015
"The Pink Sheet" Interviews Christopher Viehbacher
Now managing partner at Gurnet Point Capital, Viehbacher spoke about deal-making and other industry trends.
SOURCE: EBD Group